Articles of Association for Genmab A/S
November 15, 2017 15:40 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated November 14, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel...
Selskabsvedtægter for Genmab A/S
November 15, 2017 15:40 ET
|
Genmab A/S
Selskabsvedtægter for Genmab A/S dateret den 14. november 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance
November 14, 2017 14:49 ET
|
Genmab A/S
Company Announcement
First commercial sale of DARZALEX in Japan triggers USD 25 million in milestone payments from Janssen
Financial guidance updated
Copenhagen, Denmark; November 14,...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
November 14, 2017 12:19 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; November 14, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 22,532 shares as a consequence of the exercise of employee...
Major Shareholder Announcement
November 09, 2017 14:33 ET
|
Genmab A/S
Company Announcement
Major shareholder announcement for Genmab A/S
Copenhagen, Denmark; November 9, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the...
Genmab Announces Financial Results for the First Nine Months of 2017
November 08, 2017 11:01 ET
|
Genmab A/S
November 8, 2017; Copenhagen, Denmark;
Interim Report for the First Nine Months Ended September 30, 2017
Highlights
USD 871 million in net sales of DARZALEX® (daratumumab); resulting in...
Genmab to Present at the Jefferies 2017 London Healthcare Conference
November 07, 2017 08:56 ET
|
Genmab A/S
Media Release
Copenhagen, Denmark; November 7, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company’s CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies...
Genmab's Financial Calendar for 2018
November 03, 2017 07:31 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; November 3, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announces its financial calendar for 2018 as...
Genmab Announces Data to be Presented at 2017 ASH Annual Meeting
November 01, 2017 09:13 ET
|
Genmab A/S
Media Release
Over 25 abstracts on Genmab partnered programs scheduled for presentation at ASH
Daratumumab: 6 oral presentations; Total of over 20 abstracts accepted including...
Genmab Announces Additional Information Concerning Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2017
October 24, 2017 13:42 ET
|
Genmab A/S
Company Announcement
Johnson & Johnson confirms additional information provided on third quarter 2017 net sales
Rest of World third quarter sales reported as USD 87 million
The...